8-K ·Filed Mar 5, 2026

CYH

COMMUNITY HEALTH SYSTEMS INC
NEUTRAL
Impact 5/10
Horizonweeks Processed7mo ago SEC0001193125-26-094191
8-K material event: Items 1.01
Actionable Insight • Neutral

Monitor for closing in Q2 2026 and watch for CYH's announcement of how proceeds will be deployed, which could provide insight into future capital allocation strategy. The transaction represents a modest portfolio rationalization rather than a transformative event.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
CYH ▼ -17.91% at T+60d
NEUTRAL call ✗ call lost -17.91% · α vs SPY -30.69% · entry $3.35 → $2.75
Entry anchored
Mar 5, 03:59 PM ET
via exchange tick
T+1d
+4.78%
call +4.78% · α +3.93%
$3.51
settled 7mo ago
T+5d
-4.48%
call -4.48% · α -2.95%
$3.20
settled 7mo ago
T+20d
-11.34%
call -11.34% · α -9.30%
$2.97
settled 6mo ago
T+60d
-17.91%
call -17.91% · α -30.69%
$2.75
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Community Health Systems (CYH) has agreed to sell four Arkansas hospitals and related assets to Freeman Health System for $112 million, plus net working capital adjustments. The transaction, expected to close in Q2 2026, is part of CYH's portfolio optimization strategy and represents a divestiture of non-core assets.

Key Financial Metrics

Deal Value
$112.0M
Deal Type
acquisition

Key Facts

  • Community Health Systems (CYH) is selling four Arkansas hospitals to Freeman Health System
  • Total purchase price is $112 million, subject to net working capital and lease adjustments
  • The transaction includes Northwest Medical Center - Bentonville, Northwest Medical Center - Springdale, Northwest Medical Center - Willow Creek Women's Hospital, and Siloam Springs Regional Hospital
  • Closing expected in second quarter of 2026, subject to regulatory approvals
  • Freeman Health System is a Missouri-based nonprofit health system
  • The divestiture is part of CYH's previously announced portfolio optimization strategy

Financial Impact

Approximately $112 million in proceeds, plus net working capital adjustments

revenueasset baseoperating income

Risk Factors

  • Closing could be delayed or fail to occur due to regulatory approvals or other closing conditions
  • Potential disruption to operations during transition period
  • Impact on CYH's revenue base from divesting four facilities

Market Snapshot

Exchange
NYSE

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-094191
Document: cyh-20260305.htm0001193125-26-094191
Document: cyh-ex99_1.htm0001193125-26-094191
Document: 0001193125-26-094191-index-headers.html0001193125-26-094191
Document: 0001193125-26-094191-index.html0001193125-26-094191
Document: 0001193125-26-094191.txt0001193125-26-094191
3 reports for CYH
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CYH — sortable, filterable
TypeNow
Jun 1, 2026
17w ago
8-K
NEUTRAL ★ 5/10
$2.78 $2.92▲ +5.04%▲ +3.92%$2.72 (−2.16%)
Apr 21, 2026
23w ago
8-K
BEARISH ★ 7/10
$2.71 $3.30▼ −21.77%▼ −16.99%$2.72 (−0.37%)
Mar 5, 2026
30w ago
8-K
NEUTRAL ★ 5/10
$3.35 $2.75▼ −17.91%▼ −30.69%$2.72 (−18.81%)
Showing 3 of 3

US Market Status

Market Closed — Opens Mon (64h 38m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access